Introduction
Although five-year survival rates for childhood cancer have surpassed 85%, childhood cancer survivors continue to suffer from long-term effects decades after treatment completion. The prevalence of pulmonary dysfunction is very common at 65.2% in adulthood. This study explores early changes in the trajectory of pulmonary function in pediatric cancer patients who received pulmonary toxic therapy.